Terms: = Thyroid cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Treatment
242 results:
1. Persistent hypercalcaemia associated with two pathogenic variants in the
Leszczyńska D; Szatko A; Latocha J; Kochman M; Duchnowska M; Wójcicka A; Misiorowski W; Zgliczyníski W; Glinicki P
Front Endocrinol (Lausanne); 2024; 15():1355916. PubMed ID: 38665259
[TBL] [Abstract] [Full Text] [Related]
2. Life Expectancy After treatment of Metastatic Bone Disease: An International Trend Analysis.
Rogers DL; Raad M; Rivera JA; Wedin R; Laitinen M; Sørensen MS; Petersen MM; Hilton T; Morris CD; Levin AS; Forsberg JA
J Am Acad Orthop Surg; 2024 Mar; 32(6):e293-e301. PubMed ID: 38241634
[TBL] [Abstract] [Full Text] [Related]
3. Management of aggressive variants of papillary thyroid cancer.
Lee YK; Rovira A; Carroll PV; Simo R
Curr Opin Otolaryngol Head Neck Surg; 2024 Apr; 32(2):125-133. PubMed ID: 38116795
[TBL] [Abstract] [Full Text] [Related]
4. Effectiveness and tolerance of electrochemotherapy as palliative therapy for patients with head and neck cancer and malignant melanoma and its relation to early skin reaction.
Caballero-Borrego M; Coll S; Navarrete P
Braz J Otorhinolaryngol; 2024; 90(1):101365. PubMed ID: 38006727
[TBL] [Abstract] [Full Text] [Related]
5. [Thyroglossal duct cysts in adult : clinical and therapeutic features].
Bouatay R; Bhar S; Bouaziz N; El Korbi A; Ferjaoui M; Kolsi N; Harrathi K; Koubaa J
Rev Med Liege; 2023 Nov; 78(11):649-653. PubMed ID: 37955295
[TBL] [Abstract] [Full Text] [Related]
6. The management of pediatric Graves' disease.
Quintanilla-Dieck L
Curr Opin Otolaryngol Head Neck Surg; 2023 Dec; 31(6):419-423. PubMed ID: 37820281
[TBL] [Abstract] [Full Text] [Related]
7. Racial Disparities in 30-day Readmissions after Surgery for Head and Neck cancer.
Huang AE; Shih JJ; Sunwoo JB; Pollom E; Taparra K
Laryngoscope; 2024 Mar; 134(3):1282-1287. PubMed ID: 37610178
[TBL] [Abstract] [Full Text] [Related]
8. Financial toxicity in thyroid cancer survivors.
Bogdanovski AK; Sturgeon C; James BC
Curr Opin Endocrinol Diabetes Obes; 2023 Oct; 30(5):238-243. PubMed ID: 37470486
[TBL] [Abstract] [Full Text] [Related]
9. Recent advances in anaplastic thyroid cancer management.
Hamidi S; Maniakas A
Curr Opin Endocrinol Diabetes Obes; 2023 Oct; 30(5):259-264. PubMed ID: 37410453
[TBL] [Abstract] [Full Text] [Related]
10. The psychosocial impact of thyroid cancer.
Haymart P; Levin NJ; Haymart MR
Curr Opin Endocrinol Diabetes Obes; 2023 Oct; 30(5):252-258. PubMed ID: 37288721
[TBL] [Abstract] [Full Text] [Related]
11. Impact of the introduction of minimally invasive treatments of the thyroid (MITT) for benign thyroid nodules in an Italian hospital: a cost-minimization analysis.
Papi G; Novizio R; Brunetti M; Mauri G
Endocrine; 2023 Oct; 82(1):126-133. PubMed ID: 37258994
[TBL] [Abstract] [Full Text] [Related]
12. Utilizing Dynamic Risk Stratification in Patients With Tall Cell Variant Papillary thyroid cancer.
Zimmer D; Plitt G; Prendes B; Ku J; Silver N; Lamarre E; Yilmaz E; Geiger J; Nasr C; El Hage L; Skugor M; Cambpell S; Koyfman S; Miller J; Woody N; Heiden K; Joshi N; Elsheikh T; Li H; Scharpf J
Laryngoscope; 2023 Sep; 133(9):2430-2438. PubMed ID: 37159105
[TBL] [Abstract] [Full Text] [Related]
13. Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials?
Fanciulli G; Modica R; La Salvia A; Grossrubatscher EM; Florio T; Ferraù F; Veresani A; Russo F; Colao A; Faggiano A
Front Endocrinol (Lausanne); 2023; 14():1145926. PubMed ID: 37152939
[TBL] [Abstract] [Full Text] [Related]
14. Toxicities associated with immune checkpoint inhibitors: a systematic study.
Kong X; Chen L; Su Z; Sullivan RJ; Blum SM; Qi Z; Liu Y; Huo Y; Fang Y; Zhang L; Gao J; Wang J
Int J Surg; 2023 Jun; 109(6):1753-1768. PubMed ID: 37132038
[TBL] [Abstract] [Full Text] [Related]
15. Management of the brachial plexus in head and neck cancer.
Fockens MM; Kraak JT; Leemans CR; Eerenstein SEJ
Curr Opin Otolaryngol Head Neck Surg; 2023 Apr; 31(2):105-110. PubMed ID: 36912222
[TBL] [Abstract] [Full Text] [Related]
16. thyroid lymphoma.
Rovira A; Carroll P; Simo R
Curr Opin Otolaryngol Head Neck Surg; 2023 Apr; 31(2):83-88. PubMed ID: 36912220
[TBL] [Abstract] [Full Text] [Related]
17. Postoperative Chyle Leak Rate Following Neck Dissection for Squamous Cell Carcinoma Versus Papillary thyroid cancer.
Baker A; Tassone P; Dooley LM; Galloway TI; Zitsch RP
Laryngoscope; 2023 Nov; 133(11):2959-2964. PubMed ID: 36825523
[TBL] [Abstract] [Full Text] [Related]
18. A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?
Su J; Lu J; Zhang J; Wang M; Yan J; Lin S
Curr Opin Oncol; 2023 Mar; 35(2):132-144. PubMed ID: 36721897
[TBL] [Abstract] [Full Text] [Related]
19. Other markers of medullary thyroid cancer, not only calcitonin.
Censi S; Manso J; Mian C
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651167
[TBL] [Abstract] [Full Text] [Related]
20. Oligometastatic disease from differentiated thyroid cancer: best treatment schemes.
Colombo E; Ottini A; Licitra L
Curr Opin Oncol; 2023 Jan; 35(1):15-21. PubMed ID: 36475458
[TBL] [Abstract] [Full Text] [Related]
[Next]
